Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in vitro

Gene Therapy

Volumn 7, Issue 6, 2000, Pages 464-471

  Stevenson, A J ^a   Clarke, D ^a   Meredith, D M ^a   Kinsey, S E ^b   Whitehouse, A ^a   Bonifer, C ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Embryonic stem cells; Gene transfer; Herpesvirus saimiri; In vitro differentiation

Indexed keywords

DNA; GREEN FLUORESCENT PROTEIN; NEOMYCIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EMBRYO CELL; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HERPES VIRUS SAIMIRI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; VIRUS RECOMBINANT;

ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HERPES; HERPESVIRIDAE; SAIMIRI; SAIMIRIINE HERPESVIRUS 2; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0034059176     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301130     Document Type: Article

References (34)

1. Doetschman TC et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morph 1985; 87: 27-45.
2. Wiles MV, Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 1991; 111: 259-267.
3. Faust N et al. An in vitro differentiation system for the examination of transgene activation in mouse macrophages. DNA Cell Biol 1994; 13: 901-907.
4. Lindenbaum MH, Grosveld F. An in vitro globin gene switching model based on differentiated embryonic stem cells. Genes Dev 1990; 4: 2075-2085.
5. Lien LL, Lee Y, Orkin SH. Regulation of the myeloid-cell-expressed human gp91-phox gene as studied by transfer of yeast artificial chromosome clones into embryonic stem cells: suppression of a variegated cellular pattern of expression requires a full complement of distant cis elements. Mol Cell Biol 1997; 17: 2279-2290.
6. Orkin S. Development of the hematopoietic system. Curr Op Genetics Dev 1996; 6: 597-602.
7. Bonifer C et al. Developmental changes in the differentiation capacity of haematopoietic stem cells. Immunol Today 1998; 19: 236-241.
8. Laker C et al. Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J Virol 1998; 72: 339-348.
9. Tsuki T et al. Transgenesis by adenovirus-mediated gene transfer into mouse zona-free eggs. Nature Biotech 1998; 14: 982-985.
10. Wilson C, Bellen HJ, Gehring WJ. Position effects on eucaryotic gene expression. Ann Rev Cell Biol 1990; 6: 679-714.
11. Stevenson AJ et al. Assessment of herpesvirus saimiri as a potential human gene therapy vector. J Med Virol 1999; 57: 269-277.
12. Fleckenstein B, Desrosicrs RC. The Herpesviruses. Plenum: New York, 1992.
13. Jung JU, Desrosiers RC: Encyclopaedia of Virology. Saunders: Philadelphia, 1994.
14. Moore PS et al. Primary characterisation of a herpesvirus agent associated with kaposis-sarcoma. J Virol 1996; 70: 549-558.
15. Russo JJ et al. Nucleotide sequence of the Karposi's sarcoma associated herpesvirus (HHV8). Proc Natl Acad Sci USA 1996; 93: 14862-14867.
16. Desrosiers RC, Falk LA. Herpesvirus saimiri strain variability. J Virol 1982; 43: 352-356.
17. Medveczky P et al. Classification of herpesvirus saimiri into 3 groups based on extreme variations in a DNA region required for oncogenicity. J Virol 1984; 52: 938-944.
18. Biesinger B et al. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Prof Natl Acad Sci USA 1992; 89: 3116-3119.
19. Mittrucker H-W et al. CD2-mediated autocrine growth of herpesvirus saimiri-transformed human lymphocytes. J Exp Med 1992; 176: 909-913.
20. Grassmann R, Fleckenstein B. Selectable recombinant herpesvirus saimiri is capable of persisting in a human T-cell line. J Virol 1989; 63: 818-821.
21. Simmer B et al. Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines. J Gen Virol 1991; 72: 1953-1958.
22. Latchman DS. Genetic Manipulation of the Nervous System. Academic Press: London, 1996.
23. Knust E et al. Cloning of the herpesvirus saimiri DNA fragments representing the entire L-region of the genome. Gene 1983; 25: 281-289.
24. Walters MC et al. Transcriptional enhancers act in cis to suppress position-effect variegation. Genes Dev 1996; 10: 185-195.
25. Walters MC et al. Enhancers increase the probability but not the level of gene expression. Proc Natl Acad Sci USA 1995; 92: 7125-7129.
26. Desrosiers RC et al. A region of the Herpesvirus Saimiri genome required for oncogenicity. Science 1985; 228: 184-187.
27. Bonifer C et al. Dissection of the locus control function located on the chicken lysozyme gene domain in transgenic mice. Nucleic Acids Res 1994; 22: 4202-4210.
28. Feng Y-Q, Alami R, Bouhassira EE. Enhancer-dependent transcriptional oscillations in mouse erythroleukemia cells. Mol Cell Biol 1999; 19: 4907-4917.
29. Bonifer C et al. Prerequisites for tissue specific and position independent expression of a gene locus in transgenic mice. J Mol Med 1996; 74: 663-671.
30. Fraser P, Grosveld F. Locus control regions, chromatin activation and transcription. Curr Opin Cell Biol 1998; 10: 361-365.
31. Kelleher ZT et al. Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells. Nat Biotech 1998; 16: 762-768.
32. Robertson EJ. Embryo-derived stem cell lines. In: Robertson EJ (ed). Teratocarcinomas and Embryonic Stem Cells - a Practical Approach. IRL Press: Oxford; Washington DC, 1987, pp 71-112.
33. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5 using modified cDNA expression vectors. Eur J Immunol 1988; 18: 97-104.
34. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 1967; 26: 365-369.